GASTROINTESTINAL TUMORS
Clinical trials for GASTROINTESTINAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radioactive therapy tested for tough-to-treat cancers
Disease control Recruiting nowThis early-phase study tests a new radioactive drug called Lutetium BL-ARC001 in 22 people with advanced gastrointestinal or other solid tumors that have spread. The main goals are to check safety, find the best dose, and see if it shrinks tumors. Participants must have measurabl…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New hope for advanced tumors: early trial of BL-M24D1 begins
Disease control Recruiting nowThis early-phase study tests a new drug, BL-M24D1, in people with advanced digestive tract or other solid tumors that have spread. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 33 adults will take part in this non-randomized tr…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New hope for GIST: experimental combo targets hard-to-treat tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug (KQB198) to the standard cancer pill imatinib is safe and works better for people with advanced gastrointestinal stromal tumor (GIST). About 46 adults whose cancer has spread and who have not yet received treatment for advanced…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE2 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated May 07, 2026 18:41 UTC